Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial

Background: Terlipressin is the first-line pharmacological treatment for hepatorenal syndrome. When terlipressin is unavailable, midodrine/octreotide or norepinephrine, with albumin, represent the alternative treatments. The comparative efficacy of these alternative regimens remains unclear. Objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Desoki Mahmoud, Eman Ibrahim, Abdelaziz, Doaa H, Abd-Elsalam, Sherief, Mansour, Noha O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283260/
https://www.ncbi.nlm.nih.gov/pubmed/34276366
http://dx.doi.org/10.3389/fphar.2021.675948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283260/
https://www.ncbi.nlm.nih.gov/pubmed/34276366
http://dx.doi.org/10.3389/fphar.2021.675948

Ejemplares similares